Literature DB >> 23590852

Negative pressure therapy for high-risk abdominal wall reconstruction incisions.

Eric M Pauli1, David M Krpata, Yuri W Novitsky, Michael J Rosen.   

Abstract

BACKGROUND: A high rate of surgical site infection (SSI) accompanies the repair of large ventral hernias in the presence of bacterial contamination. Recent clinical and laboratory studies suggest that negative-pressure therapy (NPT) applied to closed surgical incisions may reduce the risk of SSI in high-risk populations. We hypothesized that NPT would reduce the risk of SSI in patients undergoing the repair of contaminated ventral hernias.
METHODS: We reviewed retrospectively our prospectively collected database for patients undergoing repair of potentially contaminated and infected ventral hernias with or without NPT. All of the patients had primary wound closure. In the NPT group, a vacuum dressing was applied over the closed midline wound. The primary outcome measure was SSI at 30 d post-operatively.
RESULTS: We evaluated 119 patients (70 with a standard wound dressing (SWD) and 49 with NPT). The groups were similar in age, gender, body mass index (BMI), the prevalence of chronic obstructive pulmonary disease (COPD), diabetes mellitus (DM), and smoking; and the number of prior abdominal operations. The SWD group had a higher American Society of Anesthesiologists (ASA) score than did the NPT group (3.0 vs. 2.8; p=0.01). The two groups were similar in the sizes of their hernia defects and duration of surgery, and did not differ in their 30-d rates of SSI (25.8% SWD vs. 20.4% NPT; p=0.50) or in the distribution of major and minor SSIs (SWD: 6 major, 12 minor vs. NPT: 2 major, 8 minor; p=0.56). Factors associated with an increased risk of SSI included ASA score (p=0.02), BMI (p=0.05), defect area (p<0.01), DM (p=0.01), and duration of surgery, (p<0.01).
CONCLUSIONS: This retrospective, non-randomized study found that NPT in the setting of a closed surgical incision after potentially contaminated or infected ventral hernia repair (VHR) did not reduce the incidence of SSI. Although prophylactic NPT has reduced wound morbidity in some surgical populations, it does not appear to offer the same reduction in wound morbidity in high-risk, contaminated, and potentially contaminated open VHR.

Entities:  

Mesh:

Year:  2013        PMID: 23590852     DOI: 10.1089/sur.2012.059

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  13 in total

1.  Closed-incision negative-pressure therapy decreases complications in ventral hernia repair with concurrent panniculectomy.

Authors:  S C Diaconu; C H L McNichols; L M Ngaage; Y Liang; E Ikheloa; J Bai; M P Grant; A J Nam; Y M Rasko
Journal:  Hernia       Date:  2018-12-17       Impact factor: 4.739

Review 2.  Does negative pressure wound therapy applied to closed incisions following ventral hernia repair prevent wound complications and hernia recurrence? A systematic review and meta-analysis.

Authors:  Edward W Swanson; Hsu-Tang Cheng; Srinivas M Susarla; Denver M Lough; Anand R Kumar
Journal:  Plast Surg (Oakv)       Date:  2016-05-27       Impact factor: 0.947

3.  Case-control study of the risk factors for acquisition of Pseudomonas and Proteus species during tigecycline therapy.

Authors:  Ga Eun Park; Cheol-In Kang; Yu Mi Wi; Jae-Hoon Ko; Woo Joo Lee; Ji Yong Lee; Sun Young Cho; Young Eun Ha; Doo Ryeon Chung; Kyong Ran Peck; Jae-Hoon Song
Journal:  Antimicrob Agents Chemother       Date:  2015-06-22       Impact factor: 5.191

4.  Positive outcomes with negative pressure therapy over primarily closed large abdominal wall reconstruction reduces surgical site infection rates.

Authors:  A Gassman; A Mehta; E Bucholdz; A Abthani; O Guerra; M M Maclin; T Esposito; C Thomas
Journal:  Hernia       Date:  2014-10-22       Impact factor: 4.739

Review 5.  Improving wound healing and preventing surgical site complications of closed surgical incisions: a possible role of Incisional Negative Pressure Wound Therapy. A systematic review of the literature.

Authors:  Alessandro Scalise; Roberto Calamita; Caterina Tartaglione; Marina Pierangeli; Elisa Bolletta; Matteo Gioacchini; Rosaria Gesuita; Giovanni Di Benedetto
Journal:  Int Wound J       Date:  2015-10-01       Impact factor: 3.315

6.  Negative-Pressure Wound Therapy in the Management of High-Grade Ventral Hernia Repairs.

Authors:  Nelson Rodriguez-Unda; Kevin C Soares; Saïd C Azoury; Pablo A Baltodano; Caitlin W Hicks; Karen K Burce; Peter Cornell; Carisa M Cooney; Frederic E Eckhauser
Journal:  J Gastrointest Surg       Date:  2015-08-04       Impact factor: 3.452

7.  Negative pressure wound therapy for managementof the surgical incision in orthopaedic surgery: A review of evidence and mechanisms for an emerging indication.

Authors:  S Karlakki; M Brem; S Giannini; V Khanduja; J Stannard; R Martin
Journal:  Bone Joint Res       Date:  2013-12-18       Impact factor: 5.853

8.  Closed incision prophylactic negative pressure wound therapy in patients undergoing major complex abdominal wall repair.

Authors:  F E E de Vries; J J Atema; O Lapid; M C Obdeijn; M A Boermeester
Journal:  Hernia       Date:  2017-05-23       Impact factor: 4.739

9.  Chinese Trauma Surgeon Association for management guidelines of vacuum sealing drainage application in abdominal surgeries-Update and systematic review.

Authors:  Yang Li; Pei-Yuan Li; Shi-Jing Sun; Yuan-Zhang Yao; Zhan-Fei Li; Tao Liu; Fan Yang; Lian-Yang Zhang; Xiang-Jun Bai; Jing-Shan Huo; Wu-Bing He; Jun Ouyang; Lei Peng; Ping Hu; Yan-An Zhu; Ping Jin; Qi-Feng Shao; Yan-Feng Wang; Rui-Wu Dai; Pei-Yang Hu; Hai-Ming Chen; Ge-Fei Wang; Yong-Gao Wang; Hong-Xu Jin; Chang-Ju Zhu; Qi-Yong Zhang; Biao Shao; Xi-Guang Sang; Chang-Lin Yin
Journal:  Chin J Traumatol       Date:  2019-02-14

Review 10.  A systematic review and meta-analysis including GRADE qualification of the risk of surgical site infections after prophylactic negative pressure wound therapy compared with conventional dressings in clean and contaminated surgery.

Authors:  Fleur E E De Vries; Elon D Wallert; Joseph S Solomkin; Benedetta Allegranzi; Matthias Egger; E Patchen Dellinger; Marja A Boermeester
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.